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1. Introduction 
Osteoarthritis (OA) is characterized by joint pain and stiffness with radiographic evidence of 
joint space narrowing, osteophytes, and subchondral bone sclerosis. Current treatments 
primarily target symptomatic control of OA, including pharmacologic therapy, local joint 
injection, and surgical interventions. Pharmaceuticals such as nonsteroidal anti-
inflammatory drugs (NSAIDs) and Acetaminophen are aimed to control inflammation and 
pain by blocking potent inflammatory cytokine pathways. Joint injections including 
glucocorticoids and hyaluranan-based formulations attempt to control inflammatory 
mediators locally and improve the glucosaminoglycan concentration within the joint space. 
Surgical procedures such as debridement, microfracture, osteochondral autografting, and 
autologous chondrocyte transplantation are currently employed to stimulate articular 
cartilage repair and delay the need for joint replacement. However, all these therapies are 
aimed at symptomatic control and have limited impact on impeding or reversing the 
progression to advanced OA. Therefore, interest has been high in development of structure 
or disease-modifying OA drugs (DMOADs) aimed at slowing, halting, or reversing the 
progression of structural damage of articular cartilage. A large number of candidate 
DMOADs have been tested but none have been approved by American or European 
regulatory agencies (Hellio Le Graverand-Gastineau, 2009; Lotz & Kraus, 2010).  
A critical barrier in drug development for OA is that molecular and cellular mechanisms for 
the development of OA, especially the mechanisms that control the activity of adult articular 
chondrocytes, remain unclear. Overexpression of proinflammatory cytokines such as 
Interleukin-1┚ (IL-1┚) and tumor necrosis factor-┙ (TNF-┙) (Goldring, 2001; Fernandes et al., 
2002), matrix-degrading proteinases such as matrix metalloproteinases (MMPs) (Burrage et 
al., 2006) and a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) 
(Glasson et al., 2005; Karsenty, 2005; Stanton et al., 2005), and nitric oxide (Pelletier et al., 
2000; Haudenschild et al., 2008; Lotz, 1999) may cause cartilage degradation. However, no 
single cytokine or proteinase can stimulate all the metabolic reactions observed in OA. Due 
to the involvement of multiple proteinases and proinflammatory cytokines in the 
pathogenesis of OA, a candidate DMOAD that inhibits a single proteinase or inflammatory 
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cytokine is unlikely to produce long-term benefit if other catabolic factors are not blocked. 
Therefore, it is critical to identify which upstream factors regulate the expression of these 
catabolic molecules in articular cartilage and other joint tissues (e.g., synovium).  
This chapter summarizes the recent advances in identification of potential upstream 
regulators such as transcription factors and specific growth factors that may control the 
expression of anabolic and/or catabolic molecules in articular cartilage and their functional 
implications in the pathogenesis and treatment of OA.  
2. Dysfunction of adult articular chondrocytes and its significance in OA 
It has been recognized that OA may develop as a result of: 1) abnormal loading on normal 
joint tissues (articular cartilage and subchondral bone); 2) normal/physiologic loading on 
abnormal/defective joint tissues; or 3) a combination of the two (Piscoya et al., 2005; Brandt 
et al., 2008; Segal et al., 2009; Buckwalter et al., 2004; Block & Shakoor, 2009; Drewniak et al., 
2009; June & Fyhrie, 2008; Borrelli et al., 2009; van der Meulen & Huiskes, 2002; Rothschild 
& Panza, 2007). Dysfunction of articular chondrocytes may be the initial change in OA with 
normal loading on abnormal articular cartilage. For OA associated with abnormal loading 
on normal joint tissues, dysfunction of articular chondrocytes is not the initial cause. 
However, mechanical disruption of the extracellular matrix and abnormal mechanotrans- 
duction in articular chondrocytes during and after joint injury or malalignment may activate 
specific signaling pathways, leading to changes in gene expression and cartilage metabolism 
as a result of dysfunction of articular chondrocytes. In order to develop effective strategies 
for prevention and treatment of OA, it is critical to understand the regulatory mechanisms 
of articular chondrocyte function.  
Mature cartilage exists in three main types: hyaline cartilage, fibrocartilage, and elastic 
cartilage. Hyaline cartilage is characterized by matrix containing type-II collagen (collagen-
2) fibers, glycosaminoglycans, proteoglycans, and multiadhesive glycoproteins. Fibro-
cartilage is characterized by abundant type-I collagen (collagen-1) fibers in addition to the 
matrix material of hyaline cartilage. Elastic cartilage is characterized by elastic fibers and 
elastic lamellae in addition to the matrix material of hyaline cartilage. Elastic cartilage is 
found in the external ear, the wall of the external acoustic meatus, the eustacchium, and the 
epiglottis of the larynx (Ross & Pawlina, 2006). Hyaline cartilage is of particular focus here 
because it is the innate component of diarthrodial joint surface involved in OA. Normal 
articular cartilage is composed of hyaline cartilage, which is divided into four zones: 1) the 
superficial tangential zone, composed of thin tangential collagen fibrils and low aggrecan 
content, 2) the middle or transitional zone, composed of thick radial collagen bundles, 3) the 
deep zone, composed of even thicker radial bundles of collagen fibrils, and 4) the calcified 
cartilage zone located between the tidemark and the subchondral bone (Goldring & Marcu, 
2009). The calcified zone persists after growth plate closure and serves as an important 
mechanical buffer between the uncalcified articular cartilage and the subchondral bone. 
Generally, cell density decreases and cell volume and relative proteoglycan content increase 
as the cartilage transitions from superficial to deep. Unlike those chondrocytes involved in 
endochondral ossification, the chondrocytes within normal articular cartilage do not 
undergo terminal differentiation, but persist and function to produce extracellular matrix 
and maintain cartilage homeostasis.  
The extracellular matrix is produced and maintained by the chondrocyte. Articular cartilage 
is characterized by the absence of blood vessels or nerves. Due to the avascularity of 
www.intechopen.com
 Transcriptional Regulation of Articular Chondrocyte Function and Its Implication in Osteoarthritis 
 
475 
articular cartilage, some nutrients are provided by diffusion of the synovial fluid. Articular 
chondrocytes have adapted to the very low oxygen tension (in the range of 1-7%) and low 
glucose levels with facilitated glucose transport via upregulation of hypoxia inducible 
factor-1 (HIF-1), expression of glucose transporter-1 and -3 (GLUT1 and GLUT3), and 
enhanced anaerobic glycolysis (Wilkins et al., 2000; Mobasheri et al., 2005; Clouet et al., 
2009). Much like bone, the physiologic properties of articular cartilage are primarily related 
to the extracellular matrix, but homeostasis in adult articular cartilage relies on the function 
of articular chondrocytes. In healthy articular cartilage, chondrocytes maintain a very low 
turnover rate of its constituents with a good balance of anabolism vs. catabolism.  
Articular cartilage undergoes changes in its material properties related to aging which are 
different from the disease process of OA, but may eventually predispose cartilage to OA or 
contribute to its progression. One such factor is the development of advanced glycation end 
products (AGEs), which enhance collagen cross-linking and make the tissue more brittle 
(Verzijl et al., 2002). Additionally, the ability of chondrocytes to respond to growth factor 
stimulation appears to decline with age, leading to decreased anabolism (Loeser & Shakoor, 
2003). Chondrocytes also demonstrate increasing senescence with age due to erosion of 
telomere length related to oxidative stress.  
OA is a disease process characterized radiographically by narrowing of joint space due to 
loss of articular cartilage, subchondral bone sclerosis, osteophyte formation, and 
subchondral cyst formation. In addition to bony changes evident on radiographs, OA also 
affects the synovium and surrounding connective tissue, indicating it is not simply a disease 
of articular cartilage (Brandt et al., 2006; Brandt et al., 2008). At the cellular and molecular 
level, OA is a disruption of normal cartilage homeostasis, generally leading to excessive 
catabolism relative to anabolism. Risk factors that contribute to development of OA include 
advanced age, joint trauma, irregular joint mechanics and malalignment, obesity, muscle 
weakness, and genetic predisposition. Although OA is not commonly referred to as an 
inflammatory arthropathy due to the lack of neutrophils in the synovial fluid and the 
absence of a systemic inflammatory response, inflammatory mediators clearly play a role in 
the progression of OA.  
In early OA, global gene expression within the chondrocyte is activated following 
mechanical injury or biological abnormalities causing increased expression of 
inflammatory mediators, cartilage-degrading proteinases, and stress-response factors 
(Fitzgerald et al., 2004; Kurz et al., 2005). Loss of proteoglycans and cleavage of collagen-2 
occurs initially at the surface of articular cartilage, causing an increase in water content 
and reduced tensile strength of the matrix (Goldring & Goldring, 2007). Chondrocyte 
clustering is one of the typical features of OA cartilage (Clouet et al., 2009). Chondrocytes 
initially attempt to synthesize and replace degraded extracellular matrix (ECM) 
components such as collagen-2, -9, and -11, aggrecan, and pericellular collagen-4 
(Buckwalter et al., 2007). This compensatory synthesis of ECM components is most 
evident among the deeper regions of articular cartilage (Fukui et al., 2008). Among the 
factors stimulating anabolism are insulin-like growth factor-1 (IGF-1), members of the 
transforming growth factor-┚ (TGF-┚) superfamily, and fibroblast growth factors (FGFs) 
(Fukui et al., 2003; Hermansson et al., 2004). These attempt to offset the degradation 
caused by inflammatory mediators such as IL-1┚, TNF-a, MMPs (e.g., MMP-1, MMP-3, 
MMP-8, MMP-13, and MMP-14), aggrecanases (e.g., ADAMTS-4 and ADAMTS-5), and 
other catabolic cytokines and chemokines.  
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As OA progresses, the synthetic balance shifts to favor catabolism, which leads to cartilage 
degradation. Significant heterogeneity in the synthetic capacity of articular chondrocytes 
occurs in OA cartilage. Overall gene activation is increased in the deep zone, but is 
decreased in the superficial zone and areas in the mid zone with degradation (Fukui et al., 
2008). Evidence of phenotypic modulation of endochondral ossification, such as collagen-1, -
3, -10, is found in osteoarthritic cartilage, which is not characteristic of normal adult articular 
cartilage (Sandell & Aigner, 2001). OA changes also occur in the subchondral bone that 
accompanies articular cartilage loss. Subchondral plate thickness increases, the tidemark 
advances, and angiogenesis invades an otherwise avascular structure (Lane et al., 1977). 
Apoptosis of the chondrocyte is seen in OA cartilage, which is mediated in part, by the 
caspases and inflammatory mediators such as IL-1 and Nitric Oxide (NO) (Kim & Blanco, 
2007).  
Another indication of aberrant behavior of osteoarthritic chondrocytes is the presence of 
collagen-10 (a marker of hypertrophic chondrocytes) and other differentiation markers, 
including annexin VI , alkaline phosphatase (Alp), osteopontin (Opn), and osteocalcin 
(Pfander et al., 2001; Pullig et al., 2000a; Pullig et al., 2000b; von der Mark et al., 1992), 
indicating that OA cartilage cannot maintain the characteristics of the permanent cartilage 
but adds those of the embryonic or growth plate cartilage. These observations suggest that 
chondrocyte maturation is likely to be deeply involved in the pathogenesis of OA. Recent 
findings on the regulatory effects of transcription/growth factors on the function of adult 
articular chondrocytes and their significance in the pathogenesis of OA are discussed below. 
3. Regulation of articular chondrocyte function and its implication in 
pathogenesis of OA  
Many governing factors that are critical for skeletal development have also been found to 
have a significant involvement in adult chondrocyte homeostasis and pathophysiology of 
OA. For instance, during skeletal development, chondrocytes in the growth plate undergo 
hypertrophic and apoptotic changes and cartilage is degraded and replaced by bone. One of 
the current hypotheses is that OA reflects the inappropriate recurrence of the hypertrophic 
pathway in articular chondrocytes. To better understand the regulatory mechanisms of 
various transcription and non-transcription factors in articular chondrocyte function, it is 
necessary to include their regulatory roles in chondrocyte differentiation, endochondral 
ossification, and joint formation during skeletal development here in this chapter.  
3.1 Chondrocyte differentiation and joint formation during skeletal development  
3.1.1 Chondrocyte differentiation and endochondral ossification 
Both the chondrocyte (cartilage-forming cell) and osteoblast (bone-forming cell) are derived 
from a common mesenchymal stem cell referred to as the osteochondroprogenitor cell. Limb 
development first begins with the formation of mesenchymal condensations and the 
subsequent formation of a surrounding cartilaginous envelope called the perichondrium. 
The progenitor cells proceed to form the anlagen, or cartilaginous template of each bone. 
Cartilage cells undergo proliferation, differentiation to functional chondrocytes, 
hypertrophic differentiation, apoptosis, calcification of cartilage, invasion of cartilage tissue 
by capillaries and chondroclasts (osteoclasts), and eventual resorption and replacement by 
newly formed bone. This process of bone formation is called endochondral ossification. The 
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primary ossification center in the diaphysis of long bones is formed through endochondral 
ossification. A similar sequence of events occurs in the growth plate leading to rapid growth 
of the skeleton. 
3.1.2 Joint formation 
At the end of each long bone an interzone and secondary ossification center develop. The 
interzone is the first sign of joint development at each future joint location, which consists of 
closely associated mesenchymal cells. Articular chondrocytes may derive from a subset of 
interzone cells, especially from the intermediate layer. Physiological separation of the 
adjacent skeletal elements occurs with further development, which involves a process of 
cavitations within the interzone that leads to formation of a liquid-filled synovial space. 
Morphological and cytodifferentiation processes extending over developmental time 
eventually lead to maturation of the joint in which the proximal and distal ends acquire 
their reciprocal and interlocking shapes. The formation of hyaline articular cartilage and 
other joint-specific tissues makes the joint fully capable of providing its physiologic roles 
through life (Pacifici et al., 2005; Mitrovic, 1978).  
3.1.3 Bone morphogenetic proteins (BMPs) and their antagonists in joint formation  
BMPs are members of the TGF-┚ superfamily. BMP was originally identified as a secreted 
signaling molecule that could induce chondrocyte differentiation and endochondral bone 
formation. Subsequent molecular cloning studies have revealed that the BMP family consists 
of various molecules, including members of the growth and differentiation factor 
(GDF/Gdf) subfamily. BMP members have diverse biological activities during the 
development of various organs and tissues, as well as embryonic axis determination 
(Hogan, 1996; Sampath et al., 1990; Wozney et al., 1988). BMP2, BMP4, BMP7, and BMP14 
(GDF5/Gdf5) are expressed in the perichondrium and are proposed to regulate cartilage 
formation and joint development (Francis-West et al., 1999; Macias et al., 1997; Zou et al., 
1997; Tsumaki et al., 2002). Gdf5, also known as cartilage-derived morphogenetic protein 1 
(CDMP-1), plays a role in chondrogenesis and chondrocyte metabolism, tendon and 
ligament tissue formation, and postnatal bone repair (Bos et al., 2008). Mutations of this 
gene are present in a number of developmental bone and cartilage diseases (Masuya et al., 
2007; Bos et al., 2008). Gdf5 has at least two roles in skeletogenesis. At early stages, Gdf5 
may stimulate recruitment and differentiation of chondrogenic cells when it is expressed 
throughout the condensations. At later stages, Gdf5 may promote interzone cell function 
and joint development when its expression becomes restricted to the interzone (Storm & 
Kingsley, 1999; Koyama et al., 2008).  
Extracellular BMP antagonists such as Noggin and Chordin can block BMP signaling by 
binding to BMP and preventing BMP binding to specific cell surface receptors. Noggin is 
expressed in condensing limb mesenchyme in mouse embryos, and expression persists in 
differentiated chondrocytes. When the Noggin gene was ablated, the mesenchymal 
condensations became much larger and limb joints failed to form, indicating that Noggin is 
critical for normal development of both long bones and joints (Brunet et al., 1998). 
Subsequent work in chick embryos showed that expression of Noggin, Chordin, and BMP-2 
characterizes the interzone once it is established, and that Chordin expression persists in 
older developing joints, while Noggin expression shifts to epiphyseal chondrocytes (Francis-
West et al., 1999). These and other data are widely acknowledged to signify that the action 
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of BMP antagonists is required to regulate the pace and extent of chondrogenesis in early 
developing long bones, and that sustained and more restricted expression and action of 
these factors in developing joints would maintain the mesenchymal character of interzone 
cells and permit normal progression of interzone function and joint formation (Hall & 
Miyake, 2000). Absence of joints in Noggin-null mice would thus be due to exuberant and 
nonphysiologic action by endogenous BMPs and, consequently, rapid and abnormal 
conversion of the entire mesenchymal condensations into chondrocytes. Though these 
conclusions are plausible and quite likely, what remains unclear is how the absence of 
Noggin leads to joint ablation; specifically, whether the interzone fails to form completely or 
whether it starts forming but cannot be sustained, whether other BMP inhibitors fail to be 
activated, or whether joint formation sites fail to respond to upstream patterning cues 
(Pacifici et al., 2005). 
3.1.4 ERG regulates the differentiation of immature chondrocytes into permanent 
articular chondrocytes  
The ERG (Ets-related gene) transcriptional activator belongs to the Ets gene family of 
transcription factors. ERG is not only expressed at the onset of joint formation, but persists 
once the articular layer has developed further. A variant of ERG named C-1-1 is expressed 
in most epiphyseal pre-articular/articular chondrocytes in developing long bones. When C-
1-1 is mis-expressed in developing chick limbs, it is able to impose a stable and immature 
articular-like phenotype onto the entire limb chondrocyte population, effectively blocking 
maturation and endochondral ossification (Iwamoto et al., 2000). More recent studies found 
that limb long bone anlagen of transgenic mice expressing the ERG variant C-1-1 were 
entirely composed of chondrocytes actively expressing collagen-9 and aggrecan as well as 
articular markers such as Tenascin-C. Typical growth plates were absent and there was very 
low expression of maturation and hypertrophy markers, including Ihh, collagen-10, and 
Mmp13. There was a close spatio-temporal relationship in the expression of both ERG and 
GDF5 that is an effective inducer of ERG expression in developing mouse embryo joints. 
These results suggest that ERG is part of the molecular mechanisms driving the 
differentiation of immature chondrocytes into permanent articular chondrocytes, and may 
do so by acting downstream of GDF5 (Iwamoto et al., 2007). 
These studies suggest that mesenchymal progenitor cells differentiate into two 
fundamentally distinct types of cartilage cells during skeletal development. The cartilage 
cells in the primary and secondary ossification centers and the growth plate undergo 
proliferation, differentiation to functional chondrocytes, hypertrophic differentiation, 
apoptosis, and eventual resorption and replacement by newly formed bone through the 
endochondral sequence of ossification. This type of cartilage is called temporal or 
replacement cartilage. In contrast, cartilage cells close to the surface of growing long bones 
divide and differentiate to form hyaline articular cartilage, which is termed permanent or 
persistent cartilage because articular chondrocytes normally do not undergo terminal 
differentiation or endochondral ossification and are not replaced by bone (Eames et al., 2004; 
Pacifici et al., 2005). 
3.2 Transcriptional regulation of articular chondrocyte function  
Factors that have been reported to regulate chondrocyte differentiation during development 
and articular chondrocyte function in the adult stage are discussed below.  
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3.2.1 Sox9 
The transcription factor Sox9 is a member of the high mobility group (HMG) and appears to 
be an essential transcription factor driving chondrogenesis during development and growth 
(Bi et al., 1999). Sox9 is expressed predominantly by mesenchymal progenitor cells and 
proliferating chondrocytes, but is not found in hypertrophic chondrocytes or osteoblasts 
(Zou et al., 2006). Sox9 is critical for the differentiation of mesenchymal progenitor cells into 
chondrocytes during cartilage morphogenesis. Prechondrocytic mesenchymal cells lacking 
Sox9 are unable to differentiate into chondrocytes (Bi et al., 1999). Joint formation is 
defective in Sox9-deficient mouse embryos (Akiyama et al., 2002). Two other members of the 
Sox family, Sox5 and Sox6 may also be essential for cartilage formation (Smits et al., 2001). 
Sox9 up-regulates the expression of chondrocyte-specific marker genes encoding collagen-2, 
collagen-9, collagen-11, and aggrecan by binding to their enhancer sequences (Evangelou et 
al., 2009). Sox9 also acts cooperatively with Sox5 and Sox6, which are present after cell 
condensation during chondrocyte differentiation, to activate collagen-2 and aggrecan genes 
(Zou et al., 2006; Lefebvre et al., 1998; Leung et al., 1998). It has been reported that the Sox 
trio (Sox 5, Sox6, Sox9) inhibit terminal stages of chondrocyte differentiation (Ikeda et al., 
2004; Saito et al., 2007); however, the precise underlying regulatory mechanism remains 
unclear. Recently, Amano et al. demonstrated that the Sox trio inhibited chondrocyte 
maturation and calcification by up-regulating parathyroid hormone related protein (PTHrP) 
(Amano et al., 2009). The anabolic effects of insulin-like growth factor-1 (IGF-1), bone 
morphogenetic protein-2 (BMP-2), and fibroblast growth factor-2 (FGF-2) on developing 
chondrocytes also appear to be mediated, in part, by Sox9 (Leung et al., 1998; Lefebvre et al., 
1998; Goldring et al., 2008; Kolettas et al., 2001; Zehentner et al., 1999). 
Despite the fact that Sox9 is critical for chondrocyte differentiation and cartilage 
morphogenesis during skeletal development (Bi et al., 1999), the expression and function of 
Sox9 in adult articular cartilage are controversial in literature. A gene expression study 
reported that Sox9 expression was lower in human OA cartilage (Brew et al., 2010). 
However, another study showed no significant difference in subcellular expression of Sox9 
protein between osteoarthritic and normal control human cartilage. Sox9 overexpression did 
not correlate with collagen-2 expression in adult articular cartilage, suggesting that Sox9 is 
not a key regulator of collagen-2 expression in human adult articular chondrocytes (Aigner 
et al., 2003). Furthermore, in vitro studies showed that overexpression of Sox9 was unable to 
restore the chondrocyte phenotype of dedifferentiated osteoarthritic articular chondrocytes 
(Kypriotou et al., 2003). These studies suggest that although Sox9 plays a crucial role in 
chondrocyte differentiation during skeletal development, its regulatory effect on the 
function of adult articular chondrocytes and development of OA remains to be elucidated.  
3.2.2 Runx2 
The transcription factor Runx2 (also called Cbfa1, Osf2, or AML3) is a member of the Runt 
family of transcription factors. Runx2 has been identified as a master regulator of osteoblast 
differentiation. Runx2-/- mice died shortly after birth and exhibited a cartilaginous skeleton 
completely void of intramembranous and endochondral ossification due to the maturational 
arrest of osteoblasts. (Komori et al., 1999; Coffman, 2003; Takeda et al., 2001; Ducy et al., 
1997; Komori et al., 1997; Otto et al., 1997). Histologic analyses of Runx2-/- mice have 
revealed delayed maturation of chondrocytes, indicating that Runx2 is involved in both 
osteogenesis and chondrogenesis (Inada et al., 1999). Eames et al. demonstrated the ability 
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of Runx2 overexpression to change permanent cartilage (e.g., articular cartilage) to temporal 
cartilage (e.g., growth plate cartilage) (Eames et al., 2004). Among the chondrogenic 
phenotypes during endochondral ossification, Runx2 is expressed mainly in the 
prehypertrophic and, to a lesser extent, in the late hypertrophic chondrocytes (Takeda et al., 
2001). Its expression coincides with Indian hedgehog (Ihh), collagen-10, and BMP-6. Matrix 
metalloproteinase-13 (MMP-13), which is expressed by terminal hypertrophic chondrocytes, 
is a downstream target of Runx2 (Hess et al., 2001). Growth arrest and DNA damage 
induceable-45┚ (GADD45┚) has been described as a probable intermediate molecule in the 
interaction between Runx2 and MMP-13 (Goldring et al., 2006; Ijiri et al., 2008; Ijiri et al., 
2005). 
In adult mice, Runx2 is expressed in the articular cartilage of wild-type mice at the early stage 
of post-traumatic knee OA, induced by surgical transection of the medial collateral ligament 
and resection of the medial meniscus. In this mouse model of OA, Runx2 expression in 
osteoarthritic cartilage parallels collagen-10 expression but arises earlier than Mmp13. After 
induction of post-traumatic knee OA by the same surgical procedure, Runx2+/- mice displayed 
decreased cartilage destruction and osteophyte formation, along with reduced expression of 
collagen-10 and MMP13, as compared with wild-type mice (Kamekura et al., 2006). Human 
OA cartilage exhibits increased Runx2 expression when compared to control cartilage. Runx2 
co-localizes with MMP13 in chondrocyte clusters of OA cartilage. Runx2 overexpression in 
cultured chondrocytes increases MMP 13 expression (Wang et al., 2004). 
These findings suggest that Runx2 regulates chondrocyte differentiation both in the 
developmental and adult stages. Runx2 may stimulate the progression of OA by promoting 
articular chondrocyte hypertrophy (indicated by expression of Collagen-10) and expression 
of MMP13 in articular cartilage (Figure 1). 
3.2.3 Nfat1 
Nfat1 (NFAT1) is a member of the Nuclear Factor of Activated T-cells (NFAT) transcription 
factor family originally identified as a regulator of the expression of cytokine genes during 
the immune response (Hodge et al., 1996; Xanthoudakis et al., 1996). Recent studies have 
shown that Nfat1 plays an important role in maintaining the permanent cartilage phenotype 
in adult mice. Nfat1 knockout (Nfat1-/-) mice exhibited normal skeletal development, but 
displayed most of the features of human OA in load-bearing joints in adults (Wang et al., 
2009; Rodova et al., 2011). Nfat1-/- articular cartilage shows overexpression of multiple 
specific proinflammatory cytokines (Figure 2A-B) and matrix-degrading proteinases (Figure 
3A) at the initiation stage of OA (2-4 months of age). These initial changes are followed by 
articular chondrocyte clustering, formation of chondro-osteophytes, progressive articular 
surface destruction, formation of subchondral bone cysts, and exposure of thickened 
subchondral bone (Wang et al., 2009), all of which resemble human OA (Pritzker et al., 
2006). The expression of mRNA for cartilage structural proteins (e.g., collagen-2, -9, and -11) 
was down-regulated but mRNA for collagen-10 was up-regulated at 2-4 months of age 
(Figure 3B). However, both collagen-2 and collagen-10 were up-regulated to varying 
degrees at 6 and 12 months, suggesting that early dysfunction of articular chondrocytes 
triggers repair activity within the degenerating cartilage (Rodova et al., 2011). These new 
findings revealed a previously unrecognized role of Nfat1 in maintaining the physiological 
function of differentiated adult articular chondrocytes by regulating the expression of 
specific matrix-degrading proteinases and proinflammatory cytokines.  
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Fig. 1. A diagram shows Runx2 involvement in the chondrocyte differentiation pathways 
toward either physiological endochondral ossification in the growth plate or pathological 
chondrocyte hypertrophy in OA cartilage. Major morphological features and extracellular 
matrix markers for each step of chondrocyte differentiation are indicated.  
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Fig. 2. Nfat1 deficiency causes dysfunction of adult articular chondrocytes with overexpression 
of specific proinflammatory cytokines. (A) Quantitative real-time PCR (qPCR) analyses 
indicate temporal changes in expression levels of various genes of proinflammatory cytokines 
in Nfat1-/- articular cartilage at 1-4 months (1-4m) of age. The expression level of each WT 
group has been normalized to “one”. n = 3 pooled RNA samples, each prepared from the 
articular cartilage of 6-8 femoral heads. * P < 0.05; ** P < 0.01. (B) Immunohisto- chemical 
analyses using a polyclonal antibody against IL-1┚ (Santa Cruz) show substantially more 
intense expression of IL-1┚ (brown areas) in femoral head articular cartilage of 3-month-old 
Nfat1-/- mice compared to age-matched WT mice. Nfat1-/- Ctl represents a negative control 
using both IL-1┚ antibody and IL-1┚ blocking peptide (Santa Cruz) to validate the specificity 
of the immune reaction. Scale bar = 200 µm. Modified from the published figure (Wang, et al. J 
Pathol 2009; 219:163-72) with permission from the publisher.  
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Fig. 3. Loss of Nfat1 leads to abnormal catabolic and anabolic activities of articular 
chondrocytes. (A) qPCR analyses demonstrate up-regulated expression of Mmp1a, 
Mmp13, and Adamts5 and reduced expression of Timp1 (tissue inhibitor of 
metalloproteinase-1) in femoral head articular cartilage of Nfat1-/- mice compared to age-
matched WT mice at 1-4 months (1-4m) of age. (B) qPCR analyses indicate temporal 
changes in expression levels of various chondrocyte marker genes in Nfat1-/- articular 
cartilage at 2-4 months (2-4m) of age. The expression level of each WT group has been 
normalized to “one”. n = 3 pooled RNA samples; * P < 0.05; ** P < 0.01. Modified from 
the published figure (Wang, et al. J Pathol 2009; 219:163-72) with permission from the 
publisher. 
Thickening of subchondral bone is one of the characteristics of human OA. However, the 
precise biological mechanisms underlying the subchondral bone changes remain unclear. 
Nfat1-/- mouse joints display chondrocyte hypertrophy in the deep-calcified zones of 
articular cartilage, a feature of human OA cartilage. Nfat1 -/- mesenchymal cells derived 
from subchondral bone marrow cavities differentiate into chondrocytes which subsequently 
underwent hypertrophy and endochondral ossification, leading to thickening of both 
subchondral plate and subchondral trabecular bone (Wang et al., 2009). These findings 
suggest that Nfat1 may prevent chondrocyte hypertrophy in adult articular cartilage and 
endochondral ossification in subchondral bone, thereby maintaining the integrity of 
cartilage-bone structure of synovial joints. 
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3.2.4 c-Maf 
Transcription factor c-Maf, a member of the basic leucine zipper (bZIP) superfamily, is 
required for normal chondrocyte differentiation during endochondral bone formation. C-
Maf is expressed in hypertrophic chondrocytes during fetal development. There is an initial 
decrease in the number of mature hypertrophic chondrocytes in c-Maf-null mouse tibiae, 
with decreased expression domains of collagen-10 and osteopontin (Opn), markers of 
hypertrophic and terminal hypertrophic chondrocytes, respectively. However, terminal 
chondrocytes, which express Opn and MMP13, appear later and persist for a longer period 
of time in c-Maf -/- fetuses than in control littermates, resulting in expanded chondrocyte 
maturation zones and a delay in endochondral ossification. These results suggest that c-Maf 
may facilitate both the initiation of terminal differentiation and the completion of the 
chondrocyte differentiation program (MacLean et al., 2003). 
A recent study demonstrated transcriptional activation of human MMP13 gene expression 
by c-Maf in osteoarthritic chondrocytes. C-Maf enhances MMP13 promoter activity and 
RNAi-mediated knockdown of c-Maf leads to a reduced expression of MMP13. Chromatin 
immunoprecipitation assays reveal that c-Maf binds to the MMP13 gene promoter, 
suggesting that MMP13 is a potential target of c-Maf in human articular chondrocytes (Li et 
al., 2010 ). 
3.2.5 β-catenin  
In the canonical Wnt signaling pathway, Wnts bind the transmembrane Frizzled receptor 
(FRZ) family and co-receptors LRP5/6. FRZ receptor activation recruits the cytoplasmic 
bridging molecule Dishevelled (Dsh) which inhibits glycogen synthase kinase-3┚ (GSK-3┚). 
This interaction prevents GSK-3┚ from phosphorylating ┚-catenin to avoid degradation of ┚-
catenin, thereby allowing ┚-catenin to accumulate in the cytoplasm and translocate to the 
nucleus as a co-transcriptional activator with lymphoid enhancing factor 1/T cell-specific 
transcription factor (LEF/TCF) at specific DNA binding sites to activate downstream genes 
(Zou et al., 2006; Deng et al., 2008). Thus, ┚-catenin is a key mediator of the canonical Wnt 
signaling. Non-canonical Wnt signaling pathway, which does not involve ┚-catenin (Logan 
& Nusse, 2004), is probably best studied in Drosophila and its function is not covered in this 
chapter.  
The canonical Wnt signaling pathway is known to induce chondrocyte maturation and 
endochondral ossification during skeletal development. This signaling pathway 
stimulates the commitment of mesenchymal stem cells to the preosteoblast and mature 
osteoblast phenotype, and blocks chondrogenic differentiation (Zou et al., 2006). 
Activation of the canonical Wnt signaling cascade during development in the limb bud 
and growth plate chondrocytes stimulates chondrocyte hypertrophy, calcification, and 
expression of MMPs and vascular endothelial growth factor (VEGF) (Tamamura et al., 
2005; Day et al., 2005; Kawaguchi, 2009). Wnt-14 overexpression in chick limb 
mesenchymal tissue cultures causes a severe inhibition of chondrogenesis. Wnt-14 is 
necessary for joint formation since it might maintain the mesenchymal nature of the 
interzone by preventing chondrogenesis. In addition to Wnt-14, the interzone expresses 
Wnt-4, Wnt-16, and ┚-catenin. Conditional ablation of ┚-catenin in chondrocytes leads to 
the absence of joints. Ectopic expression of activated ┚-catenin or Wnt-14 in chondrocytes 
leads to ectopic expression of joint markers (Tamamura et al., 2005; Hartmann & Tabin, 
2001; Guo et al., 2004).  
www.intechopen.com
 Transcriptional Regulation of Articular Chondrocyte Function and Its Implication in Osteoarthritis 
 
485 
The canonical Wnt signaling is also important in susceptibility to OA. Recent studies 
revealed that Wnt/┚-catenin is involved in chondrocyte maturation and endochondral 
ossification in adult chondrocytes. The inhibition of Dickkopf-1 (Dkk1), a negative regulator 
of the Wnt signal, has been reported to allow conversion of a mouse model of rheumatoid 
arthritis to OA, due to increased endochondral ossification (Diarra et al., 2007). The 
conditional activation of ┚-catenin in articular chondrocytes of adult mice caused OA-like 
cartilage degradation and osteophyte formation. These pathological changes were 
associated with accelerated chondrocyte maturation and Mmp expression (Zhu et al., 2009). 
Interestingly, the same group also reported that selective suppression of ┚-catenin signaling 
in articular chondrocytes also caused OA-like cartilage degradation in Col2a1-ICAT 
(inhibitor of ┚-catenin and T-cell factor) transgenic mice, and this was mediated by 
enhancement of apoptosis of the chondrocytes (Zhu et al., 2008). These results suggest that 
both excessive and insufficient ┚-catenin levels may impair the homeostasis of articular 
chondrocytes.  
Transcription factors and transcriptional co-activators that may be responsible for the 
maintenance of the physiological function of adult articular chondrocytes and development 
of OA are presented in Figure 4. 
 
 
Fig. 4. A diagram demonstrates specific factors that may be responsible for the expression of 
catabolic molecules and collagen-X (Col-X, a marker of hypertrophic chondrocytes) during 
the development of OA. 
3.3 Other factors that may regulate chondrocyte differentiation and function  
3.3.1 BMPs 
A variety of BMP members are present in articular cartilage. Among these BMPs, BMP-2 and 
BMP-7 (osteogenic protein-1, OP-1) are the two best studied BMPs with regard to cartilage 
homeostasis and OA. Both BMP-2 and BMP-7 have been shown to be capable of maintaining 
the chondrocyte phenotype. Inhibition of BMP-7 causes a reduction of aggrecan gene 
expression in chondrocytes. It has been reported that BMP-7 expression is decreased up to 9-
fold in degenerated cartilage. In contrast to BMP-7, BMP-2 expression appears to increase with 
cartilage damage. In a study of BMPs in OA, BMP-2 is the only BMP member that demonstrates 
an increase in OA cartilage compared to cartilage from normal joints (Chubinskaya et al., 2007; 
Chubinskaya et al., 2000; Fukui et al., 2003; Sailor et al., 1996; Soder et al., 2005). 
Multiple polymorphisms of the GDF-5 (BMP-14) gene have been found to produce an 
increased Odds Ratio of OA development, but the one that appears to have the most robust 
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correlation is the rs143383 SNP in the 5’-UTR of GDF5. Miyamoto et al. reported a strong 
association between the rs143383 SNP of GDF5 and hip and knee OA in multiple Asian 
populations, with Odds Ratios ranging from 1.30-1.79 (Miyamoto et al., 2007). This 
association was confirmed in a large-scale meta-analysis; however, the magnitude of effect 
was less than previously reported (Evangelou et al., 2009). Interestingly, Egli et al. found that 
GDF5 expression imbalance was not limited to articular cartilage, but found in multiple joint 
tissues analyzed (synovium, fat pad, meniscus, ligaments) (Egli et al., 2009).  
3.3.2 Insulin-like growth factor-1 (IGF-1) 
IGF-1 is expressed in normal articular cartilage and is generally thought to be an important 
growth factor for maintenance of articular chondrocyte phenotype and articular cartilage 
repair (Fortier et al., 2002; Fortier et al., 2011). Chronic IGF-1 deficiency causes an increased 
severity of OA-like articular cartilage lesions in rat knee joints (Ekenstedt et al., 2006). 
Human OA cartilage responds to IGF-1 treatment by increasing proteoglycan synthesis; 
however, catabolism in OA cartilage is insensitive to IGF-1 treatment (Morales, 2008).  
3.3.3 Indian hedgehog (Ihh) 
Ihh is a member of the hedgehog proteins, and is essential for skeletal development. Ihh 
coordinates chondrocyte proliferation, chondrocyte differentiation, and osteoblast 
differentiation. Ihh is synthesized by prehypertrophic chondrocytes and by early 
hypertrophic chondrocytes during endochondral ossification. Ihh knockout (Ihh-/-) mice 
demonstrate abnormalities of chondrocyte differentiation and bone growth. Cartilage 
elements are small in Ihh-/- mice because of a marked decrease in chondrocyte proliferation. 
Ihh-/- chondrocytes leaving the pool of proliferating chondrocytes prematurely because  
Ihh-/- cartilage fails to synthesize parathyroid hormone-related protein (PTHrP) that acts 
primarily to keep proliferating chondrocytes in the proliferative pool. PTHrP, which is 
expressed by perichondral cells and early proliferative chondrocytes, down-regulates the 
expression of Ihh. This negative feedback loop mainly regulates the rate of chondrocyte 
differentiation and endochondral ossification. A third striking abnormality of Ihh-/- mice is 
the absence of osteoblasts in the primary spongiosa, suggesting that Ihh is required for 
osteoblast differentiation in endochondral bone formation (Kronenberg, 2003; Karp et al., 
2000). Ihh is a critical and possibly direct regulator of joint development. In Ihh-/- mouse 
embryos, cartilaginous digit anlagen remained fused without interzones or mature joints 
(Koyama et al., 2007). 
A recent study revealed that PTHrP may regulate articular chondrocyte maintenance in 
mice (Macica et al., 2011). In addition, parathyroid hormone (PTH) 1-34, a parathyroid 
hormone analog sharing the PTH receptor 1 with PTHrP, may inhibit the terminal 
differentiation of human articular chondrocytes in vitro and suppresses the progression of 
OA in rats (Chang et al., 2009).  
3.3.4 Fibroblast growth factors (FGFs) 
Recent evidence suggests that the FGF family plays an essential role in the proliferation and 
differentiation process of chondrocytes. The impact of many of these factors is not fully 
understood, but multiple FGF and FGFR (FGF receptor) genes are expressed at every stage 
of endochondral ossification. Within the chondrocyte pathway, FGFR3 is found in 
proliferating chondrocytes, FGFR1 in prehypertrophic and hypertrophic chondrocytes, and 
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FGFR2 is expressed among the earliest condensing mesenchyme (Ornitz & Marie, 2002). 
FGFs markedly enhance Sox9 expression in the early stages of development, likely through 
the mitogen-activated protein kinase (MAPK) pathway (Murakami et al., 2000).  
The regulatory effects of FGF on adult articular chondrocytes are controversial in literature. 
A recent study showed that FGF-2 is an intrinsic chondroprotective agent that suppresses 
ADMTS5 and delays cartilage degradation in murine OA (Chia et al., 2009). However, other 
studies suggested that FGF-2 and FGF-23 may be involved in the progression of OA by 
stimulating MMP-13 expression through Runx2 (Orfanidou et al., 2009; Wang et al., 2004).  
4. Future perspectives on pharmacological therapy 
Over the past two decades, clinical trials applying a proinflammatory cytokine or proteinase 
inhibitor as a candidate disease-modifying OA drug (DMOAD) have been unsuccessful due 
to insufficient efficacy and/or severe side effects. A large number of candidate DMOADs 
have been tested but none have been approved (Hellio Le Graverand-Gastineau, 2009; 
Kawaguchi, 2009); suggesting that inhibition of a single catabolic molecule may not be 
sufficient for the treatment of OA because multiple catabolic factors are involved in its 
pathogenesis. Since specific transcriptional signaling molecules (e.g. Nfat1, Runx2, c-Maf, ┚-
catenin) may regulate the expression of multiple catabolic and/or anabolic factors in 
articular chondrocytes, these regulatory factors may play more important roles in the 
development of OA than a single catabolic proteinase/cytokine. These findings have 
opened new avenues toward the development of DMOADs, using a more upstream factor 
as a molecular target than has been studied heretofore. In addition, OA not only affects 
articular cartilage but also involves other joint tissues such as the subchondral bone, 
synovium, capsule, menisci, and ligaments. Pathological changes in these joint tissues may 
affect the biological and mechanical properties of articular cartilage. Therefore, other joint 
tissues should not be ignored when designing pharmacological therapies. Furthermore, 
insufficient recognition of pathological changes in mechanical influence on the pathogenesis 
of OA may also negatively affect the efficacy of DMOAD candidates (Brandt et al., 2008). 
These recent research advances in the pathogenesis and treatment of OA may lead to the 
development of novel and effective therapeutic strategies using more up-stream 
pharmacological targets such as transcriptional signaling molecules, combined with 
biomechanical correction of abnormal joint loading if necessary, for the prevention and 
treatment of human OA.  
5. Conclusion 
OA is the most common form of joint disease and the major cause of chronic disability in 
middle-aged and older populations. All current pharmacological therapies are aimed at 
symptomatic control and have limited impacts on impeding or reversing the progression of 
OA, largely because the biological mechanisms of OA pathogenesis remain unclear. 
Previous studies have shown that overexpression of matrix-degrading proteinases and 
proinflammatory cytokines in articular cartilage is associated with osteoarthritic cartilage 
degradation. However, clinical trials applying an inhibitor of a proteinase or 
proinflammatory cytokine have been unsuccessful. Since multiple catabolic factors and 
pathological chondrocyte hypertrophy are involved in the development of OA, it is 
important to identify which upstream factors regulate the expression of catabolic molecules 
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and/or chondrocyte hypertrophy in adult articular cartilage. This chapter summarizes the 
recent advances in the molecular regulation, with a main focus on transcriptional regulation, 
of the function of adult articular chondrocytes and its implication in the pathogenesis and 
treatment of OA. Recent studies have revealed that biological and mechanical abnormalities 
may affect transcriptional activity of specific transcription factors in articular chondrocytes. 
Transcription factor Sox9 is critical for the formation of cartilage, including articular 
cartilage, but its role in maintenance of adult articular chondrocyte function remains to be 
elucidated. Transcription factor Nfat1 plays an important role in maintaining the 
physiological function of adult articular chondrocytes. Nfat1-deficient mice exhibit normal 
skeletal development but display most of the features of human OA in their adult stage, 
including chondrocyte hypertrophy with overexpression of specific matrix-degrading 
proteinases and proinflammatory cytokines in articular cartilage. Transcription factor Runx2 
and ┚-catenin transcriptional signaling may also be involved in the pathogenesis of OA via 
regulating the expression of anabolic and catabolic molecules in articular chondrocytes. 
These novel findings may provide new insights into the pathogenesis and treatment of OA. 
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